Diphenylamine sulfate, 98.0%, 1g

4-amino-1-(3,4-dihydroxy-5-(hydroxymethyl)-3-methyltetrahydrofuran-2-yl)pyrimidin-2(1H)-one, 95.0%, 250mg

N-[2-[[4-[4-(3-Bromo-4-fluorophenyl)-4,5-dihydro-5-oxo-1,2,4-oxadiazol-3-yl]-1,2,5-oxadiazol-3-yl]amino]ethyl]sulfamide, 95%, 100mg

2-Butanone, min. 99.5%, for synthesis, 5 l, alu

2-Morpholin-4-yl-2-phenyl-ethylamine, 95.0%, 500mg

trans-1,2-Dichloroethylene (stabilized with MEHQ)>98.0%(GC)25g

{5-[morpholin-4-yl(phenyl)methyl]-1H-tetrazol-1-yl}acetic acid, 95.0%, 5g

4-(4-Nitrophenoxy)benzoic acid, 95.0%, 25g

3-CHLOROOXETANE, 95.0%, 100mg

[1,1'-Biphenyl]-2,4-diol, 97.0%, 1g

2-(6-Bromohexyloxy)tetrahydro-2H-pyran, 95%, 1g

4-tert-Butylpyrocatechol>98.0%(GC)25g

1-((2R,3R,4S,5R)-3,4-Dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-4-thioxo-3,4-dihydropyrimidin-2(1H)-one, 95.0%, 25mg